share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

艾伯维公司 | 4：持股变动声明-董事 Alpern Robert J
美股sec公告 ·  07/02 16:49
Moomoo AI 已提取核心信息
In a recent transaction dated 06/30/2024, Robert J Alpern engaged in a stock market activity involving shares of AbbVie Inc. [ABBV]. The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed. Consequently, the number of shares held by Alpern after the transaction remains unknown. This event may be of interest to investors monitoring insider activities within AbbVie Inc.
In a recent transaction dated 06/30/2024, Robert J Alpern engaged in a stock market activity involving shares of AbbVie Inc. [ABBV]. The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed. Consequently, the number of shares held by Alpern after the transaction remains unknown. This event may be of interest to investors monitoring insider activities within AbbVie Inc.
最近一次交易日为06/30/2024，Robert J Alpern参与了AbbVie股份公司[ABBV]的股票市场活动。交易的具体细节，包括交易的股票数量，股份的性质，交易价格和股份的总价值，均未披露。因此，交易后Alpern所持有的股份数量仍然未知。这一事件可能会引起投资者对AbbVie Inc.内部交易的关注。
最近一次交易日为06/30/2024，Robert J Alpern参与了AbbVie股份公司[ABBV]的股票市场活动。交易的具体细节，包括交易的股票数量，股份的性质，交易价格和股份的总价值，均未披露。因此，交易后Alpern所持有的股份数量仍然未知。这一事件可能会引起投资者对AbbVie Inc.内部交易的关注。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息